Home » Topics » Regulatory » Patents

Patents
RSS

Dopamine D4-selective compounds, therapeutic and diagnostic uses disclosed by Resolution

Feb. 19, 1999

Roche discloses inhibitors of TNF-alpha/TGF-alpha release, keratinocyte proliferation

Feb. 18, 1999

Patent covers new ADIR compounds with high affinity for imidazoline receptors

Feb. 18, 1999

More from SmithKline Beecham on p38 MAP kinase inhibitors

Feb. 18, 1999

New series of anticoagulants for oral administration developed at Lilly

Feb. 18, 1999

Specific inhibitors of MEK for cancer and other proliferative disorders

Feb. 18, 1999

DuPont patents novel CRF antagonists for wide range of conditions

Feb. 17, 1999

Tachykinin antagonists in early development at Pfizer

Feb. 17, 1999

New quinolones from Dong Wha with improved Gram-positive activity and high safety

Feb. 17, 1999

Lilly's new orally active anticoagulants

Feb. 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...